These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20076586)

  • 1. Trapped: a molecular-level look at how herpes disables its immune destroyer.
    Hoff M
    PLoS Biol; 2006 Jun; 4(6):e189. PubMed ID: 20076586
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.
    Sprague ER; Wang C; Baker D; Bjorkman PJ
    PLoS Biol; 2006 Jun; 4(6):e148. PubMed ID: 16646632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular specificity of IgG-Fc interactions with Fc gamma receptors.
    Mimura Y; Ghirlando R; Sondermann P; Lund J; Jefferis R
    Adv Exp Med Biol; 2001; 495():49-53. PubMed ID: 11774607
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.
    Dubin G; Basu S; Mallory DL; Basu M; Tal-Singer R; Friedman HM
    J Virol; 1994 Apr; 68(4):2478-85. PubMed ID: 7511171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction sites on human IgG-Fc for FcgammaR: current models.
    Jefferis R; Lund J
    Immunol Lett; 2002 Jun; 82(1-2):57-65. PubMed ID: 12008035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII.
    Ghirlando R; Keown MB; Mackay GA; Lewis MS; Unkeless JC; Gould HJ
    Biochemistry; 1995 Oct; 34(41):13320-7. PubMed ID: 7577916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y; Satoh T; Yagi H; Yanaka S; Yamaguchi T; Isoda Y; Iida S; Okamoto Y; Kato K
    Sci Rep; 2017 Oct; 7(1):13780. PubMed ID: 29062024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conformational change in the Fc precludes the binding of two Fcgamma receptor molecules to one IgG.
    Kato K; Fridman WH; Arata Y; Sautès-Fridman C
    Immunol Today; 2000 Jul; 21(7):310-2. PubMed ID: 10871868
    [No Abstract]   [Full Text] [Related]  

  • 11. Single molecule Förster resonance energy transfer studies of the effect of EndoS deglycosylation on the structure of IgG.
    Piraino MS; Kelliher MT; Aburas J; Southern CA
    Immunol Lett; 2015 Sep; 167(1):29-33. PubMed ID: 26112419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors.
    Sondermann P; Oosthuizen V
    Immunol Lett; 2002 Jun; 82(1-2):51-6. PubMed ID: 12008034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
    Ju MS; Na JH; Yu YG; Kim JY; Jeong C; Jung ST
    Mol Immunol; 2015 Oct; 67(2 Pt B):350-6. PubMed ID: 26153451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The difference of binding epitopes on human CD16 (FcgammaRIII) interacted with hIgG1 and monoclonal antibody B88-9.
    Feng J; Xie Z; Yu M; Guo N; Shen B
    Mol Immunol; 2004 May; 41(1):93-8. PubMed ID: 15140580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
    Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
    J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric human Fc-fusion proteins with modified effector functions.
    Mekhaiel DN; Czajkowsky DM; Andersen JT; Shi J; El-Faham M; Doenhoff M; McIntosh RS; Sandlie I; He J; Hu J; Shao Z; Pleass RJ
    Sci Rep; 2011; 1():124. PubMed ID: 22355641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
    Lubinski JM; Jiang M; Hook L; Chang Y; Sarver C; Mastellos D; Lambris JD; Cohen GH; Eisenberg RJ; Friedman HM
    J Virol; 2002 Sep; 76(18):9232-41. PubMed ID: 12186907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.